The Antidepressant Drugs Market is valued at USD 16.22 Billion in 2026 and is expected to reach USD 18.43 Billion by 2032, expanding at a CAGR of 2.15% over the forecast period. Steady demand is fueled by the rising global prevalence of major depressive disorders (MDD), anxiety, and mood conditions, alongside a growing focus on early clinical intervention. https://manjiri0564.livejournal.com/119715.html?newpost=1